The EDC is live today — see what ships now
All studies
NCT07551986From ClinicalTrials.govRecruiting

Building Cognitive Resilience to Vaccine Misinformation Using AI in Europe

Building Cognitive Resilience to Vaccine Misinformation Using Conversational AI: Evidence From a Multi-Country European Randomised Trial

  • Healthy

At a glance

Phase
Phase not stated
Study type
Interventional
Sponsor
London School of Hygiene and Tropical Medicine
Enrolment target
5,000
Started
5 June 2026
Main results due
December 2026
Study sites
1
Registry updated
29 September 2026

Can you take part?

  • Aged 20 years and over.
  • Open to any sex.
  • Healthy volunteers can take part.

These are the headline rules only. Every study has a longer list, and whether you are eligible is decided by the research team at the site — never by this page.

Read the full eligibility criteria
Inclusion Criteria:

* Parents or caregivers with children under 18 years old in the five target countries (UK, Netherlands, Croatia, Latvia, and Slovakia); and
* Those who have regular access to a digital device and the internet

Exclusion Criteria:

* Participants who do not meet the inclusion criteria.

What this study is about

In the sponsor’s own words, from the registry.

This multi-country trial evaluates an AI chatbot designed to counter cognitive biases and inoculate parents against vaccine misinformation, embedded within a large survey across five European countries (n=5,000). Scaled from a 2026 single-country study, outcomes compare behavioural and attitudinal responses against standard-of-care materials (e.g., UNICEF infographics) to identify effective, scalable misinformation interventions.

Study sites(1)

  • London School of Hygiene and Tropical Medicine

    London, United Kingdom

    Recruiting

Showing 1 of 1 sites. 1 of the 1 site on this study is recruiting right now — a site can stop enrolling while the study as a whole is still open.

Source: ClinicalTrials.gov record NCT07551986. Trialion does not run this study, is not paid to refer anyone to it, and cannot enrol you. Eligibility is always decided by the research team at the site.

Not the right study?

Answer three questions and see the studies recruiting near you, in plain language.

Find a study for me
Building Cognitive Resilience to Vaccine Misinformation Using AI in Europe | Trialion